HD-OPM Archive
Topics › Statins

N-of-1 trial: most statin side effects arose with placebo too, pointing to nocebo

Louis Nervegna · Feb 24, 2025 · ♥ 11 reactions · 15 comments · original Facebook post
StatinsHow to read research
AI summary & key facts

Louis highlights a NEJM N-of-1 trial where people who had stopped statins for side effects received four months of statin, four of placebo and four of nothing, randomly ordered. Symptoms with placebo were about the same as with statin, and half could restart statins; Louis infers about 90% of side effects were nocebo.

On any given month, the participants were randomized to either a statin, a placebo, or nothing at all.

What happened is that participants reported very little side effects from taking nothing, but lots of side effects from taking either the placebo or the statin.

The only reasonable explanation for that is nocebo effect. In this study, 90% of the side effects were due to nocebo effect.

↪ Nocebo effect explained about 90% of symptoms in patients who quit statins (SAMSON trial)

People who are prone to conspiratorial lines of thinking about medical topics are much more likely to experience nocebo effect. This is why you should always take testimonials from these people with a grain of salt.

facebook.com/share/r/1BPLbqjcwe

#noceboHD #statinsHD #nejmHD #samsonHD

Research cited

Patients who had discontinued statins because of side effects received four one-month bottles of a statin, four bottles of placebo, and four empty bottles, randomly sequenced, each to be used for 1 month. Symptom burden with placebo was not significantly different to the symptom burden with the statin, and half the study participants were able to successfully restart statins.

← newer: Anabolic steroid use linked to 3x heart attack and 9x cardioolder: Serious liver problems from statins are rare and routine liv →